Intelligence Platform
Patents
Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 10201597
Codon-optimized lentiviral vector for stem cell reprogramming
granted patentUS 10201516
Targeting K-Ras-mediated signaling pathways and malignancy by prostratin
granted patentUS 10201282
Genetically encoded infrared fluorescent protease reporters
granted patentUS 10196458
Anti-immunoglobulin E antibodies and methods of using thereof
granted patentUS 10195222
Acyclic nucleoside phosphonate diesters
granted patentUS 10190097
Method and composition for inducing human pluripotent stem cells
granted patentUS 10189881
MPS peptides and use thereof
granted patentUS 10188769
Biocompatible substrate for facilitating interconnections between stem cells and target ti
granted patentUS 10188633
Identification of small molecules that facilitate therapeutic exon skipping
granted patentUS 10188461
Selective fat removal using photothermal heating
granted patentUS 10182984
Targeted interferons demonstrate potent apoptotic and anti-tumor activities
granted patentUS 10179112
Viral vector nanocapsule for targeting gene therapy and its preparation
granted patentUS 10175170
Metal coating of rare earth nano-phosphors and uses thereof
granted patentUS 10172938
Multimode degradable hydrogels for controlled release of cargo substances
granted patentUS 10172844
Use of CDK9 inhibitors to reduce cartilage degradation
granted patentUS 10172831
Catalytic scavengers of organophosphates to potentiate butyrylcholinesterase (hBChE) as a
granted patentUS 10167334
Treatment of cancer using anti-TGF-BETA and PD-1 antibodies
granted patentUS 10167295
Analgesic compounds and methods of use
granted patentUS 10166271
Methods for promoting hair growth
granted patentUS 10165788
Methods and compositions for improved digestion of milk oligosaccharides
granted patentUS 10160954
Engineered physical alignment of stem cell-derived cardiomyocytes
granted patentUS 10155798
Anti-obesity compounds derived from neuromedin U
granted patentUS 10155796
Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor
granted patentUS 10155014
Cyclic di-AMP induction of type I interferon
granted